Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,152 | 33,703 | 30,355 | 51,426 | 64,752 |
| Marketable Securities | 332,560 | 269,586 | 286,520 | 275,590 | 274,008 |
| Receivables | N/A | N/A | 750 | N/A | 500 |
| TOTAL | $355,195 | $309,302 | $321,399 | $332,439 | $344,330 |
| Non-Current Assets | |||||
| PPE Net | 7,317 | 7,378 | 7,203 | 7,086 | 6,514 |
| Other Non-Current Assets | 24,338 | 24,820 | 24,354 | 24,485 | 24,912 |
| TOTAL | $31,655 | $32,198 | $31,557 | $31,571 | $31,426 |
| Total Assets | $386,850 | $341,500 | $352,956 | $364,010 | $375,756 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,505 | 1,910 | 2,051 | 2,159 | 2,866 |
| Accrued Expenses | 6,831 | 9,216 | 7,737 | 8,179 | 7,240 |
| Other current liabilities | 25 | 30 | 35 | N/A | 323 |
| TOTAL | $14,471 | $17,904 | $16,114 | $16,507 | $16,335 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,648 | 5,340 | 4,935 | 5,406 | 5,906 |
| Other Non-Current Liabilities | 23,431 | 23,820 | 24,184 | 24,542 | 24,092 |
| TOTAL | $23,431 | $24,127 | $25,578 | $26,763 | $27,908 |
| Total Liabilities | $37,902 | $42,031 | $41,692 | $43,270 | $44,243 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,168 | 46,139 | 41,833 | 41,833 | 41,663 |
| Common Shares | 46 | 42 | 42 | 42 | 42 |
| Retained earnings | -157,005 | -145,437 | -127,929 | -110,470 | -94,405 |
| Other shareholders' equity | -1,175 | -1,060 | -739 | -1,535 | -2,277 |
| TOTAL | $348,948 | $299,469 | $311,264 | $320,740 | $331,513 |
| Total Liabilities And Equity | $386,850 | $341,500 | $352,956 | $364,010 | $375,756 |